Detalhe da pesquisa
1.
Effective implementation of the Accelerate Pheno™ system for positive blood cultures.
J Antimicrob Chemother
; 74(Suppl 1): i40-i43, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30690541
2.
Further evidence of reliability and validity of the Huntington's disease quality of life battery for carers: Italian and French translations.
Qual Life Res
; 22(5): 1093-8, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22821667
3.
DNA instability in replicating Huntington's disease lymphoblasts.
BMC Med Genet
; 10: 11, 2009 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19210789
4.
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.
Eur J Nucl Med Mol Imaging
; 36(7): 1113-20, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19280185
5.
Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy?
J Neurol Sci
; 277(1-2): 143-6, 2009 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19059613
6.
Affinity purification of IgG monoclonal antibodies using the D-PAM synthetic ligand: chromatographic comparison with protein A and thermodynamic investigation of the D-PAM/IgG interaction.
J Immunol Methods
; 333(1-2): 126-38, 2008 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18313690
7.
The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea.
Neurosci Lett
; 393(1): 27-30, 2006 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-16221531
8.
Identification and refinement of a peptide affinity ligand with unique specificity for a monoclonal anti-tenascin-C antibody by screening of a phage display library.
J Chromatogr A
; 1107(1-2): 182-91, 2006 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-16414054
9.
Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life Instrument.
Int Clin Psychopharmacol
; 27(4): 208-14, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22508443
10.
De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementia.
BMJ Case Rep
; 20092009.
Artigo
em Inglês
| MEDLINE | ID: mdl-21686668
11.
Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease.
CNS Neurosci Ther
; 15(1): 1-11, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19228174
12.
Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutations.
Am J Med Genet B Neuropsychiatr Genet
; 144B(5): 691-5, 2007 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-17440989
13.
New Huntington disease mutation arising from a paternal CAG34 allele showing somatic length variation in serially passaged lymphoblasts.
Am J Med Genet B Neuropsychiatr Genet
; 133B(1): 127-30, 2005 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-15546151